Stock futures edged lower Monday morning as President Trump authorized a 100% tariff on foreign-made movies. Read more on ...

Discover insights from a 30-year net lease investor on tenant strategies, REIT risks, and top picks like Broadstone and ...

XSW underperforms concentrated peers like IGV despite strong sector tailwinds and projected 11.3% CAGR. Read why XSW ETF is a ...

Dover’s growth in liquid cooling and pharma pumps offsets some risk, but stretched valuation and macro headwinds remain. Read ...

Bitcoin miners like Riot Platforms are performing terribly, which is in part attributable to the BTC halving in April 2024.

HelloFresh Q1 2025 revenue dipped 6.9% YoY but EBITDA soared 36% above forecasts. Click here to find out why we rate HLFFF ...

Alliance Resource Partners' Q1 2025 results show steady growth despite challenges in Appalachian operations. Check out why I ...

Orkla's focus on core business and asset divestment has been driving stock gains. Click here to read the full investment ...

HACK is a thematic ETF focused on cybersecurity, with strict rebalancing and weighting rules. Check out why I believe it's ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

It remains to be seen how the new management team will lead Patriot National Bancorp. Click here to read why PNBK stock is a ...

Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...